COVID antivirals: Who is eligble for Paxlovid and molnupiravir and how can I get them?

Press/Media: Expert Comment

Description

Article describing the variations in criteria and access barrier for antiviral medications to prevent progression of COVID 19

Subject

COVID-19

Antiviral

Pharmaceutical Benefits Scheme

National COVID-19 Clinical Evidence Taskforce

Period9 Jun 2022

Media contributions

1

Media contributions

  • TitleCOVID antivirals: Who is eligible for Paxlovid and molnupiravir and how can I get them?
    Degree of recognitionNational
    Media name/outletABC Online
    Media typeWeb
    Country/TerritoryAustralia
    Date9/06/22
    DescriptionArticle describing barriers and complications of accessing COVID-19 antiviral treatments
    Producer/AuthorBelinda Smith
    PersonsMark Morgan